A

Arvinas

D
ARVN
USD
-0.36
(-1.4229%)
Market Closed
12,851.00
حجم التداول
-4.1
الربح لكل سهم
-
العائد الربحي
-4.705660
P/E
1,712,082,641.34
حجم السوق
اليوم
-1.4229%
1 اسبوع
-10.126%
1 شهر
-2.806%
6 اشهر
-20.319%
12 اشهر
25.960%
بداية السنة
-39.466%
كل الوقت
0%
avatar
sara abdelazim
عدد النقاط
112
عدد التوصيات
2

Title:
Arvinas

Sector:
Healthcare
Industry:
Biotechnology
Arvinas Inc is a United States-based biopharmaceutical company focused on improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development and commercialization of therapies that degrade disease-causing proteins.. The company's proprietary Proteolysis-Targeting Chimera (PROTAC), work by inducing the cell's own ubiquitin-proteasome system to target, degrade and remove disease-causing proteins. The group's product candidates are bavdegalutamide, ARV-471 and ARV-766.
هل تحتاج مساعدة او لديك استفسار؟